ITPD20020138A1 - Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima. - Google Patents

Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.

Info

Publication number: ITPD20020138A1
Authority: IT; Italy
Prior art keywords: terpenic; dispersion; environment; preparation; composition
Prior art date: 2002-05-24

Application number

IT2002PD000138A

Other languages

English (en)

Inventor

Matteo Bevilacqua

Original Assignee

Matteo Bevilacqua

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-24

Filing date

2002-05-24

Publication date

2003-11-24

2002-05-24 Application filed by Matteo Bevilacqua filed Critical Matteo Bevilacqua

2002-05-24 Priority to IT2002PD000138A priority Critical patent/ITPD20020138A1/it

2002-05-24 Publication of ITPD20020138A0 publication Critical patent/ITPD20020138A0/it

2003-05-23 Priority to US10/515,656 priority patent/US20060222723A1/en

2003-05-23 Priority to AU2003242563A priority patent/AU2003242563A1/en

2003-05-23 Priority to EP03755117A priority patent/EP1507545A1/en

2003-05-23 Priority to PCT/EP2003/005412 priority patent/WO2003099302A1/en

2003-05-23 Priority to JP2004506826A priority patent/JP2005533767A/ja

2003-11-24 Publication of ITPD20020138A1 publication Critical patent/ITPD20020138A1/it

Links

239000006185 dispersion Substances 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000000126 substance Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Natural Medicines & Medicinal Plants (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Alternative & Traditional Medicine (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Medical Informatics (AREA)
Botany (AREA)
Biotechnology (AREA)
Psychiatry (AREA)
Tropical Medicine & Parasitology (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Rheumatology (AREA)
Addiction (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Medicines Containing Plant Substances (AREA)

IT2002PD000138A 2002-05-24 2002-05-24 Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima. ITPD20020138A1 (it)

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
IT2002PD000138A ITPD20020138A1 (it)	2002-05-24	2002-05-24	Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.
US10/515,656 US20060222723A1 (en)	2002-05-24	2003-05-23	Terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere
AU2003242563A AU2003242563A1 (en)	2002-05-24	2003-05-23	A terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere
EP03755117A EP1507545A1 (en)	2002-05-24	2003-05-23	A terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere
PCT/EP2003/005412 WO2003099302A1 (en)	2002-05-24	2003-05-23	A terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere
JP2004506826A JP2005533767A (ja)	2002-05-24	2003-05-23	テルペン基材組成物、その調製方法および大気散布方法

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT2002PD000138A ITPD20020138A1 (it)	2002-05-24	2002-05-24	Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.

Publications (2)

Publication Number	Publication Date
ITPD20020138A0 ITPD20020138A0 (it)	2002-05-24
ITPD20020138A1 true ITPD20020138A1 (it)	2003-11-24

Family

ID=11452532

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT2002PD000138A ITPD20020138A1 (it)	2002-05-24	2002-05-24	Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.

Country Status (6)

Country	Link
US (1)	US20060222723A1 (it)
EP (1)	EP1507545A1 (it)
JP (1)	JP2005533767A (it)
AU (1)	AU2003242563A1 (it)
IT (1)	ITPD20020138A1 (it)
WO (1)	WO2003099302A1 (it)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10331750A1 (de) *	2003-07-14	2005-02-10	Keyneurotek Ag	Verwendung der Hydrierungsprodukte von Weihrauch (Olibanum) zur Prophylaxe und/oder Behandlung von zerebraler Ischämie, Schädel/Hirntrauma und/oder Alzheimer-Krankheit
ITMI20031390A1 (it) *	2003-07-08	2005-01-09	Turispharma S R L	Metodo di estrazione di strutture molecolari attive da resine naturali e/o da oli essenziali.
JP4832082B2 (ja) *	2004-02-03	2011-12-07	久光製薬株式会社	経皮薬物投与装置用インタフェース
US7871377B2 (en) *	2005-01-21	2011-01-18	Aveda Corporation	Method of evaluating human subconscious response to smell
US20060269567A1 (en) *	2005-05-16	2006-11-30	Liu Yuen	Universal detoxifying composition
JP4918259B2 (ja) *	2006-01-06	2012-04-18	株式会社キャタラー	低分子有機ガス吸収材及びこれを用いた燃料蒸気処理装置
JP2007332126A (ja) *	2006-06-16	2007-12-27	Teikyo Univ	ヒトおよび愛玩動物のための抗白癬入浴剤
WO2008017280A1 (de) *	2006-08-10	2008-02-14	Franz Udo Willerscheidt	Soporus; sedativum mit myrrhe und süssholzwurzel
WO2009117987A2 (de) *	2008-03-26	2009-10-01	Universität Tübingen	Verwendung von boswelliasäuren und synthetischen boswelliasäurederivaten zur hemmung der mikrosomalen prostaglandin e2 synthase und des cathepsin g
GB2471523A (en)	2009-07-03	2011-01-05	Gw Pharma Ltd	Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
CA2779025A1 (en)	2009-10-28	2011-05-05	Regenera Pharma Ltd.	Therapeutic uses of oligomeric and polymeric monoterpenes
TWI583374B (zh) *	2010-03-30	2017-05-21	Ｇｗ伐瑪有限公司	使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
GB2487712B (en)	2011-01-04	2015-10-28	Otsuka Pharma Co Ltd	Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
CN102670689A (zh) *	2011-03-14	2012-09-19	苏州博创园生物医药科技有限公司	治疗银屑病喷雾剂的制备方法
GB2495118B (en)	2011-09-29	2016-05-18	Otsuka Pharma Co Ltd	A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
CN102670740B (zh) *	2012-05-28	2014-01-15	石家庄平安医院有限公司	一种治疗软组织损伤的药物组合物及其制备方法
ITPD20120343A1 (it) *	2012-11-13	2014-05-14	Matteo Bevilacqua	Composto in particolare per la cura della depressione e dell'ansia
GB2530001B (en)	2014-06-17	2019-01-16	Gw Pharma Ltd	Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
GB2527599A (en)	2014-06-27	2015-12-30	Gw Pharma Ltd	Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
GB2531281A (en)	2014-10-14	2016-04-20	Gw Pharma Ltd	Use of cannabidiol in the treatment of intractable epilepsy
GB2531278A (en)	2014-10-14	2016-04-20	Gw Pharma Ltd	Use of cannabidiol in the treatment of intractable epilepsy
GB2531282A (en)	2014-10-14	2016-04-20	Gw Pharma Ltd	Use of cannabinoids in the treatment of epilepsy
CN104491458B (zh) *	2015-01-08	2017-09-19	魏财禧	一种中药外用药及其制备方法与应用
GB2539472A (en)	2015-06-17	2016-12-21	Gw Res Ltd	Use of cannabinoids in the treatment of epilepsy
GB2541191A (en)	2015-08-10	2017-02-15	Gw Pharma Ltd	Use of cannabinoids in the treatment of epilepsy
GB2548873B (en)	2016-03-31	2020-12-02	Gw Res Ltd	Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
GB2551987A (en)	2016-07-01	2018-01-10	Gw Res Ltd	Oral cannabinoid formulations
GB2551986A (en)	2016-07-01	2018-01-10	Gw Res Ltd	Parenteral formulations
GB2553139A (en)	2016-08-25	2018-02-28	Gw Res Ltd	Use of cannabinoids in the treatment of multiple myeloma
GB2557921A (en)	2016-12-16	2018-07-04	Gw Res Ltd	Use of cannabinoids in the treatment of angelman syndrome
US10675264B2 (en)	2017-02-07	2020-06-09	Elevate Technologies Llc	Terpene-based compositions, methods of preparations and uses thereof
GB2559774B (en)	2017-02-17	2021-09-29	Gw Res Ltd	Oral cannabinoid formulations
GB2560019A (en)	2017-02-27	2018-08-29	Gw Res Ltd	Use of cannabinoids in the treatment of leukaemia
GB2564383B (en)	2017-06-23	2021-04-21	Gw Res Ltd	Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex
CN107296896B (zh) *	2017-06-28	2020-06-30	高康日化集团有限公司	一种治疗胶质瘤的药物组合物及其制备方法
CN107519322B (zh) *	2017-10-20	2021-01-05	葛洪伟	通过泄殖腔给药方式防治母鸡输卵管炎的中药喷剂
GB2568929A (en)	2017-12-01	2019-06-05	Gw Res Ltd	Use of cannabinoids in the treatment of epilepsy
GB2569961B (en)	2018-01-03	2021-12-22	Gw Res Ltd	Pharmaceutical
JP7325425B2 (ja)	2018-02-08	2023-08-14	ネオンクテクノロジーズインク．	血液脳関門を透過性にする方法
EP4058503B1 (en) *	2020-01-14	2024-10-16	P2 Science, Inc.	Vicinal diol ether derivatives of polyether polymers
GB202002754D0 (en)	2020-02-27	2020-04-15	Gw Res Ltd	Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
GB202009321D0 (en)	2020-06-18	2020-08-05	Gw Res Ltd	Use of cannabinoids in the treatment of epilepsy
US11160757B1 (en)	2020-10-12	2021-11-02	GW Research Limited	pH dependent release coated microparticle cannabinoid formulations
US12653330B2 (en) *	2022-02-16	2026-06-16	Goppion S.P.A.	Method for improving behaviour of a museum display case with respect to objects exhibited therein
CA3264785A1 (en)	2022-08-12	2024-02-15	Jazz Pharmaceuticals Research Uk Limited	ORAL SOLID DOSAGE FORMS CONTAINING CANNABINOIDS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS57179101A (en) *	1981-04-27	1982-11-04	Lion Corp	Repellent for bloodsucking vermin
US4826686A (en) *	1985-12-14	1989-05-02	Boehringer Ingelheim Kg	Therapeutic system
JPH0551301A (ja) *	1991-08-23	1993-03-02	Osaka Gas Co Ltd	防菌・防黴性香気発生具
US5629351A (en) *	1995-04-13	1997-05-13	Council Of Scientific & Industrial Research	Boswellic acid compositions and preparation thereof
US6077513A (en) *	1996-05-02	2000-06-20	Massoud; Ahmed Mohamed Ali	Drug for treatment of bilharziasis (Schistosomiasis)

2002
- 2002-05-24 IT IT2002PD000138A patent/ITPD20020138A1/it unknown
2003
- 2003-05-23 AU AU2003242563A patent/AU2003242563A1/en not_active Abandoned
- 2003-05-23 WO PCT/EP2003/005412 patent/WO2003099302A1/en not_active Ceased
- 2003-05-23 US US10/515,656 patent/US20060222723A1/en not_active Abandoned
- 2003-05-23 EP EP03755117A patent/EP1507545A1/en not_active Withdrawn
- 2003-05-23 JP JP2004506826A patent/JP2005533767A/ja active Pending

Also Published As

Publication number	Publication date
ITPD20020138A0 (it)	2002-05-24
US20060222723A1 (en)	2006-10-05
JP2005533767A (ja)	2005-11-10
WO2003099302A1 (en)	2003-12-04
EP1507545A1 (en)	2005-02-23
AU2003242563A1 (en)	2003-12-12

Publication	Publication Date	Title
ITPD20020138A0 (it)	2002-05-24	Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.
NO20055018D0 (no)	2005-10-27	Anti-amyolide antistoffer, sammensetninger, fremgangsmater og anvendelser
EP1298180A4 (en)	2005-03-09	HYDROPHOBIC AND LIPOPHOBE COMPOSITION
DE60326611D1 (de)	2009-04-23	N und dergleichen
ITTO20010940A0 (it)	2001-10-04	,,sedia,,
DK1534277T3 (da)	2012-01-09	Acylerede, heteroaryl-kondenserede cycloalkenylaminer og anvendelse af disse som lægemidler
GB0215044D0 (en)	2002-08-07	Sampling kits, devices and uses thereof
DK1511734T3 (da)	2010-08-02	Forbindelser, præparater og fremgangsmåder
FR2849381B1 (fr)	2005-02-25	Composition cosmetique, solaire et bio-bronzante
FI20030893L (fi)	2004-12-14	Näppäimistö ja menetelmä sen valmistamiseksi
AU2003207199A1 (en)	2003-09-04	Structure, method of manufacturing the same, and device using the same
BR0312460B1 (pt)	2013-05-28	suporte sàlido, processo de preparaÇço, e, uso do mesmo.
DE60318139D1 (de)	2008-01-31	Isolator- und Anordnungskonfiguration
AU2003297079A1 (en)	2004-07-29	Anti-filming materials, compositions and methods
EP1539792A4 (en)	2005-12-21	CNGH0005 POLYPEPTIDES, ANTIBODIES, COMPOSITIONS, METHODS AND USES
GB0202871D0 (en)	2002-03-27	Assays,methods and means
DK1573016T3 (da)	2014-07-28	Genreporterassay, -kit og -celler.
ITRM20020108V0 (it)	2002-05-29	Stazione di gioco e di lavoro.
BR0316841B1 (pt)	2012-12-25	corante reativo e o uso do mesmo.
ITRM20010116A0 (it)	2001-03-05	Indicatore goniometricoastronomico, in particolare solare e/o lunare.
ITBS20030016A1 (it)	2004-08-22	Dispositivo di bloccaggio per sedie da ufficio e simili.
ITMI20022425A1 (it)	2003-05-20	Distanziatore e distanziale.
NO20044090L (no)	2004-11-04	Substituert 3-fenyl-5-alkoksy-1,3,4-oksadiazol-24neJr, fremstilling derav og anvendelse i medikamenter
NO20055142D0 (no)	2005-11-02	Diarylmetylidenpiperidinderivater, fremstillinger og anvendelser derav
SE0303065D0 (sv)	2003-11-18	New composition, methods and uses thereof